Appearance of nuclear protease activity after embryonal carcinoma cells undergo differentiation

Developmental Biology

Volumn 173, Issue 2, 1996, Pages 420-427

  Scholtz, Beáta ^a,b   Lamb, Kimberly ^a,b   Rosfjord, Edward ^a,b   Kingsley, Michelle ^a,b   Rizzino, Angie ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPAIN; APROTININ; CALPASTATIN; CHYMOSTATIN; LEUPEPTIN; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PEPSTATIN; PROTEINASE; SOYBEAN TRYPSIN INHIBITOR; TRANSCRIPTION FACTOR;

ARTICLE; CELL DIFFERENTIATION; EMBRYONAL CARCINOMA; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0030039974     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1006/dbio.1996.0037     Document Type: Article

References (39)

1. Adamson, E. D., Evans, M. J., and Magrane, G. G. (1977). Biochemical markers of the progress of differentiation in cloned teratocarcinoma cell lines. Eur. J. Biochem. 79, 607-615.
2. Barrett, A. J., Kembhavi, A. A., Brown, M. A., Kirschke, H., Knight, C. G., Tamai, M., and Hanada, K. (1982). L-trans-epoxysuccinyl-leucylamido(4-guanidino)butane (E64)and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J. 201, 189-198.
3. Bond, J. S., and Butler, P. E. (1987). Intracellular proteases. Annu. Rev. Biochem. 56, 333-364.
4. Dailey, L., Yuan, H., and Basilico, C. (1994). Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer. Mol. Cell. Biol. 14, 7758-7769.
5. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983). Accurate transcription initiation by RN Apolymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489.
6. Driever, W., Thoma, G., and Nusslein-Volhard, C. (1989). Determination of spatial domains of zygotic gene expression in the Drosophila embryo by the affinity of the binding sites for the bicoid morphogen. Nature 340, 363-367.
7. Du, W., Thanos, D., and Maniatis, T. (1993). Mechanism of transcriptional synergism between distinct virus-inducible enhancer elements. Cell 74, 887-898.
8. Fried, M., and Crothers, D. M. (1981). Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res. 9, 6505-6525.
9. Hasan, S., Koda, T., and Kakinuma, M. (1994). An upstream NF-Y-binding site is required for transcriptional activation from the hst promoter in F9 embryonal carcinoma cells. J. Biol. Chem. 269, 25042-25048.
10. Heussen, C., and Dowdle, E. B. (1980). Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102, 196-202.
11. Jiang, J., and Levine, M. (1993). Binding affinities and cooperative interactions with bHLH activators delimit threshold responses to the dorsal gradient morphogen. Cell 72, 741-752.
12. Kelly, D., O'Reilly, M., and Rizzino, A. (1992). Differential regulation of the transforming growth factor type-β2 gene promoter in embryonal carcinoma cells and their differentiated cells. Dev. Biol. 153, 172-175.
13. Kelly, D., Scholtz, B., Orten, D. J., Hinrichs, S. H., and Rizzino, A. (1995). Regulation of the transforming growth factor-β2 gene promoter in embryonal carcinoma cells and their differentiated cells: Differential utilization of transcription factors. Mol. Reprod. Dev. 40, 135-145.
14. Lamph, W. W., Wamsley, P., Sassone-Corsi, P., and Verma, I. M. (1988). Induction of protooncogene JUN/AP-1 by serum and TPA. Nature 334, 629-631.
15. Maki, M., Bagci, H., Hamaguchi, K., Ueda, M., Murach, T., and Hatanaka, M. (1989). Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene. J. Biol. Chem. 264, 18866-18869.
16. Mellgren, R. L. (1991). Proteolysis of nuclear proteins by μ-calpain and m-calpain. J. Biol. Chem. 266, 13920-13924.
17. Mellgren, R. L., and Lu, Q. (1994). Selective nuclear transport of μ-calpain. Biochem. Biophys. Res. Commun. 204, 544-550.
18. Nichols, M., Weih, F., Schmid, W., DeVack, C., Kowenz-Leutz, E., Luckow, B., Boshart, M., and Schutz, G. (1992). Phosphorylation of CREB affects its binding to high and low affinity sites: Implications for cAMP induced gene transcription. EMBO J. 11, 3337-3346.
19. Nixon, R. A. (1989). Calcium activated neutral proteinases as regulators of cellular functions. Implications for Alzheimer's disease pathogenesis. Ann. N.Y. Acad. Sci. 568, 198-208.
20. Noma, T., Glick, A. B., Geiser, A. G., O'Reilly, M. A., Miller, J., Roberts, A. B., and Sporn, M. B. (1991). Molecular cloning and structure of the human transforming growth factor-β2 gene promoter. Growth Factors 4, 247-255.
21. Palombella, V. J., and Maniatis, T. (1992). Inducible processing of interferon regulatory factor-2. Mol. Cell. Biol. 12, 3325-3336.
22. Ramsay, G., Evan, G. I., and Bishop, J. M. (1984). The protein encoded by the human proto-oncogene c-myc. Proc. Natl. Acad. Sci. USA 81, 7742-7746.
23. Rizzino, A. (1988). Transforming growth factor-β: Multiple effects on cell differentiation and extracellular matrices. Dev. Biol. 130, 411-422.
24. Rizzino, A. (1993). Understanding the roles of growth factors in carcinogenesis: Modulation of autocrine growth control by differentiation. Int. J. Dev. Biol. 37, 61-65.
25. Rizzino, A., Orme, L. S., and DeLarco, J. E. (1983). Embryonal carcinoma cell growth and differentiation. Exp. Cell Res. 143, 143-152.
26. Ron, D., Brasier, A. R., McGehee, R. E., Jr., and Habener, J. F. (1992). Tumor necrosis factor-induced reversal of adipocytic phenotype of 3T3-L1 cells is preceded by a loss of nuclear CCAAT/enhancer binding protein (C/EBP). J. Clin. Invest. 89, 223-233.
27. Rosfjord, E., Scholtz, B., Lewis, R., and Rizzino, A. (1995). Phosphorylation and DNA binding of the octamer binding transcription factor Oct-3. Biochem. Biophys. Res. Commun. 212, 847-853.
28. Scholtz, B., Kelly, D., and Rizzino, A. (1995). Cis-regulatory elements and transcription factors involved in the regulation of the transforming growth factor-β2 gene. Mol. Reprod. Dev. 41, 140-148.
29. Squier, M. K. T., Miller, A. C. K., Malkinson, A. M., and Cohen, J. J. (1994). Calpain activation in apoptosis. J. Cell. Physiol. 159, 229-237.
30. Suzuki, K. (1987). Calcium activated neutral protease: Domain structure and activity regulation. Trends Biochem. Sci. 12, 103-105.
31. Suzuki, K., Saido, T. C., and Hirai, S. (1992). Modulation of cellular signals by calpain. Ann. N.Y. Acad. Sci. 674, 218-227.
32. Swillens, S., and Pirson, I. (1994). Highly sensitive control of transcriptional activity by factor heterodimerization. Biochem. J. 301, 9-12.
33. Tanaka, K., Kumatori, A., Ii, K., and Ichihara, A. (1989). Direct evidence for nuclear and cytoplasmic colocalization of proteasomes (multiprotease complexes) in liver. J. Cell. Physiol. 139, 34-41.
34. Thanos, D., and Maniatis, T. (1992). The high mobility group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene. Cell 71, 777-789.
35. Tiesman, J., and Rizzino, A. (1990). Nucleotide sequence of the 5′ flanking region of the mouse k-FGF oncogene exhibits an alternating purine: Pyrimidine motif with the potential to form Z-DNA. Gene 96, 311-312.
36. Tokés, Z. A., and Clawson, G. A. (1989). Proteolytic activity associated with the nuclear scaffold. J. Biol. Chem. 264, 15059-15065.
37. Umezawa, H., and Aoyagi, T. (1983). Trends in research of low molecular weight protease inhibitors of microbial origin. In "Proteinase Inhibitors: Medical and Biological Aspects" (N. Katunuma et al., Eds.), pp. 3-15. Japan Sci. Soc., Tokyo/Springer-Verlag, Berlin.
38. Wang, X., Sato, R., Brown, M. S., Hua, X., and Goldstein, J. L. (1994). SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 77, 53-62.
39. Watt, F., and Molloy, P. L. (1993). Specific cleavage of transcription factors by the thiol protease, m-calpain. Nucleic Acids Res. 21, 5092-5100.